Trial Profile
Clinical Trials Insight: 700020654
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2007
Price :
$35
*
At a glance
- Drugs Peginterferon lambda-1a (Primary)
- Indications Hepatitis C; Viral infections
- Focus Adverse reactions
- Sponsors ZymoGenetics
- 02 Feb 2007 New trial record.